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It has been shown that para-aminobenzoic acid and certain of its esters are
excellent filtering agents for protection of the human skin against the erythema-
producing part of the sunlight spectrum (1, 2). Recently an ester of para-amino-
benzoic acid, namely monoglycerol para-aminobenzoate, has been incorporated
in a number of widely used commercial sunburn preventives. The advantages of
this new compound over the older sunfiltering agents used on human skin are, in
addition to its filtering capacity, its lack of odor and its lack of staining proper-
ties. In a preliminary report (3) we cited a case of allergic eczematous contact-
type hypersensitivity to the monoglycerol ester of para-aminobenzoic acid, which
to our knowledge was the first case of this kind described. The present report
deals with the detailed findings in this case which are of interest because of the
widespread use of sunburn preventives containing monoglycerol para-amino-
benzoate, and because of the occurrence in this case of a number of cross-sensiti-
zations to various other important chemicals which are encountered in every day
life.
CASE REPORT
R. R., a man, aged 47, had suffered from a chronic dermatosis which had started at the
age of 18 and which had been diagnosed as a combined atopic dermatitis and seborrheic
dermatitis.
During the past few years the eruption had been under fairly good control with the ex-
ception of occasional flareups on the face, particularly after trips in Pullman cars,1 and two
attacks of dermatitis of the hands. One of these was in March 1947 when he developed an
acute vesicular eruption on the hands while in Florida on vacation. The other attack took
place in July 1947, while on a cruise, when he developed an acute vesicular eruption, similar
to the one in March 1947. The history suggested, as a possible cause of these two attacks a
commercial sunburn preventive containing monoglycerol para-aminobenzoate which the
patient had used preceding both attacks of dermatitis.
Through the cooperation of the manufacturer all eight ingredients of the sun-
burn preventive were obtained in the concentrations in which they are present in
the commercial preparation. The patient was then patch tested with these in-
dividual materials and the combination of all ingredients as contained in the
commercial sunburn preventive. He showed a 4 plus reaction to monoglycerol
para-aminobenzoate in alcohol and a 3 plus reaction to the whole preparation
which he had used preceding the attacks of dermatitis, but negative reactions to
all the other individual ingredients of the sunburn preventive.
In view of the possibility of cross-sensitization to various chemically related
Received for publication July 18, 1948.
1 We were unable to investigate further this angle of our case as the Pullman Company
refused to reveal the nature of the insect sprays, cleaning agents, etc., used in its cars.
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TABLE 1
Results of patch tests on R. II.
SUBSTANCE EEMICAL STRUCV7RE REACTION
Benzocaine H2NOC2H6 ++++
Butesin H2NOC4H9
Para-aminobenzoic acid H2NOH
Paraphenylenediamine H2N<'NH2 ++++
Aniline H2N ++++
Monoglycerol para-ami- IIN(CHCHOHCHOH + +++
nobenzoate
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Procaine H2NC_O—C2H4(
CH
0 NH2
II /
Sulfaguanidine HIN<>-_S-_N=C
Sulfanilamide H2NLNH2
&ccharin 1\/J\ / ++S
0 0
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TABLE 1—Continued
SVBSTANCE CNEMICAL STRUCTURE REACTION
C'
CH3CONH<>N=N' ++Azodye "A"
OH
OH
NO
Picc Acid +-++
NO2
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H2NK/—-N—C CII\IIl/
Sulfadiazine II / +O N—-CH
C2H5
CONHCIH4N<
Nupercaine C4Hg +
N
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0
CH1C2H5
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TABLE 1—Concluded
SUBSTANCE CEEmCAL STRUCTURE REACTION
Apothesine L\) ,O C2H
HC=CH. C—O—C3HGN<
C,H5
NH2
Menthyl anthranilate
COOCHz{,,j
0
C411, 0 OH,/
Pontocaine HN\__>C_OCSHIN
OH,
Phenol 0
NH2
Anthranilic acid
011J
3,5 Dinitrobenzoic acid
NOJ0NO,
0
Ce— OH
NO2
Paranitrobenzoic acid o
Ce-OH
compounds the patient's previous history was reviewed and two significant
features were elicited: 1) in 1939 patch tests with 29 different therapeutic agents
were negative except for a 4 plus reaction to 10% benzocaine in alcohol, 2) in
1944 while in North Africa the patient took a sulfonamide, very probably sulfa-
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guanidine, for protection against dysentery and within 24 hours developed a
vesicular eruption on the palms and soles. This evidence suggested that this
patient had indeed developed allergic eczematous cross-sensitizations to a wide
range of materials.
INVESTIGATION OF SENSITIVITY
Patch tests with various substances in standard concentrations were applied
to the skin of our patient with the results as indicated in Table 1.
COMMENT
It seems quite probable that this patient's hypersensitivity to benzocaine
(ethylaminobenzoate), discovered in 1939, was the first link in the chain of sensi-
tizations to para-aminobenzoic acid and related compounds. The first clinical
manifestation of cross-sensitization was the vesicular eruption on his hands in
1944 which followed the ingestion of a sulfonamide, probably sulfaguanidine,
even though it was the first time that he had been exposed to a sulfonamide.
By virtue of the then existent sensitization to benzocaine, it is likely that he was
already sensitized to other derivatives of para-aminobenzoic acid. This suppo-
sition is substantiated by the fact that in March 1947 when he first used a sun-
burn preventive containing monoglycerol para-aminobenzoate he promptly
developed a vesicular eruption on his hands. Again in July, 1947 when he had
occasion to use the same preparation, a similar eruption appeared.
However, the sensitization was not restricted to para-aminobenzoic acid and
its derivatives, as seen from the review of the compounds to which our patient
yielded reactions on patch testing, namely monoglycerol para-aminobenzoate,
procaine, benzocaine, butesin, para-aminobenzoic acid, paraphenylenediamine,
aniline, sulfaguanidine, picric acid and azodye A. These various compounds
have one feature in common, namely a primary aromatic amino group and in
most cases in the para position on this amino group basic or acid groups.
The negative reactions in our patient to other local anesthetics, namely sto-
vaine, alypin, apothesine and pontocaine indicate that one important factor is
the presence of a primary amino group; the first three compounds do not have
an amino radical in the para position, while pontocaine contains a secondary
aromatic amine.
In the literature there are many reports of cases of allergic hypersensitivity to
certain compounds of the group of substances to which our patient was hyper-
sensitive; but we have found only a few reports on cases with as wide a spectrum
of hypersensitivity as was noted in our patient. At another time we shall review
the meaning of the crossing over of sensitivity to a variety of related and appar-
ently non-related substances. We shall restrict the discussion of our case
mainly to a comparison of his group-hypersensitivity with the cross-sensitizations
among various local anesthetics as reported by other investigators.
Schwarzschild (4) in 1928, was the first to investigate the phenomenon of cross-
sensitization in hypersensitivity to local anesthetics. He came to the conclusion
that in sensitization to orthoform (para-aniinometaoxybenzoic methyl ester), the
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presence of the OH group in the para or meta position on the aminobenzoic acid
radical was probably the deciding feature in producing cross-sensitization. On
the other hand, he found in patients sensitized to benzocaine, cross-sensitizations
to cycloform (isobutyl para-aminobenzoate) and propaesin (propyl para-amino-
benzoate), which seems to indicate that in this case the cross-sensitization was
based on the presence of a para-aminobenzoyl radical.
NH2
C
COO—
In James' case (5) of dermatitis due to procaine the hypersensitivity appears
to have been directed against certain aliphatic tertiary amines, as his patient
reacted to diethylaminoethanol.
NH2
O
Procaine C2H5 Diethylaminoethanol
0 C2H5 N—CH2CH2OH/ /
C—O—CH2 CH2 N C2H5
C 2H
It is probable that the sensitization in Waidron's (6) case of a dentist who had
an eczema due to contact with a variety of local anesthetics may be explained on
the same basis, since the hypersensitivity comprised various derivatives of ben-
zoic acid having a tertiary amine in the side chain (procaine, tutocaine, butyn,
metycaine and pontocaine). Waidron's patient was, however, not tested with
enough related substances to be certain of the correctness of this theory.
The hypersensitivity in Goodman's (7) patient, which was due to daily use of
eyewash containing procaine, in many ways resembles that in our own case, in
spite of some differences. Goodman attributed the cross-sensitizations in his
patient to hypersensitivity to the para-aminobenzoyl group, as in James' case
(5). However, similar to our case there was a strong hypersensitivity to aniline.
Sidi (8) called attention to the occurrence of hypersensitivity to aniline in cases
of allergic hypersensitivity to local anesthetics. Goodman's patient also reacted
to pontocaine and to certain of the phenols including metaaminophenol.
Rothman, Orland and Flesch (9) revealed still another type of group hyper-
sensitivity to local anesthetics in a dentist with hypersensitivity to procaine
hydrochloride. Their patient revealed reactions to the alkyl esters of para-
aminobenzoic acid (which include benzocaine), to local anesthetics which are
benzoic acid derivatives with tertiary amines in the side chain including stovaine,
apothesine, nupercaine and to compounds with the amino radical in the meta or
the ortho position. Positive results were obtained only with such esters of para-
aminobenzoic acid with a side chain containing secondary or tertiary amines.
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Positive results with pontocaine indicated that the amine in the para position on
the benzene ring could either be primary or secondary (see also discussion of
Goodman's case).
Strauss (10) reported 2 cases of allergic hypersensitivity to local anesthetics.
One of these he interpreted to confirm the occurrence of crossing over of sensi-
tivity to local anesthetics and the other to indicate that group sensitivity does not
necessarily always take place. His case with group sensitivity was hypersensi-
tive to the entire group of those local anesthetics which belong to the group of
para-aminobeuzoic acid esters with a secondary or tertiary amine in the side
chain. His other case showed hypersensitivity to pontocaine alone at first and
then to apothesine two weeks after the initial application. One may assume that
this was a case of sensitization to apothesine induced by the initial patch test with
this substance and probably independent of cross sensitization.
Laden and Rubin (11) recently reported a patient with a hypersensitivity
spectrum restricted to the alkyl esters of para-aminobenzoic acid.
In summary this review of the literature on sensitization to local anesthetics
shows that many different patterns of eczematous hypersensitivity to local
anesthetics exist. Some patients have a very narrow range of hypersensitivity
while others have cross sensitizations to a wide range of local anesthetics and
other substances (see below). It must be recognized that in some patients not
all positive reactions to patch tests with local anesthetics can be explained satis-
factorily on the basis of cross-sensitization. Possible explanations for this are
the existence of independent hypersensitivities (polyvalent but specific) or the
conversion in the skin of certain compounds into other compounds which fall
within the scope of cross-sensitization.
In contrast to the aforementioned cases we find that the results of testing in our
patients revealed a far greater and more potentially dangerous field of cross-
sensitization than to local anesthetics alone.
One of the most important features is the crossing of the hypersensitivity to
the sulfonamides. Crossing over of eczematous allergic hypersensitivity from
sulfonamides to para-aminobenzoic acid and local anesthetics has been previously
discussed by Sulzberger, Kanof and Baer (12). We tested our patient only with
sulfaguanidine, sulfanilamide and sulfadiazine, to all of which he reacted.
The occurrence of eczematous cross-sensitization between sulfonamides and
para-aminobenzoic acid is not only of interest in connection with skin sensitiza-
tion. The possibility must be weighed that this type of cross-sensitization may
also occur in sensitizations affecting other organs or structures in the human
body. For example it has recently been noted that the oral administration of
large doses of salts of para-aminobenzoic acid tends to produce granulocytopenia
in some subjects (personal communication, Dr. C. R. Rein). Is it not likely that
in such patients granulocytopenia or agranulocytosis, conditions which are prob-
ably based on specific allergic sensitization (Squires and Madison), can also be
elicited by sulfonamides on the basis of allergic cross-sensitization? And if this
hypothesis is correct could it not be that certain azodyes ingested in foods could
contribute to prolonging, aggravating or maintaining granylocytopenic states?
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Only recently the administration of para-aminobenzoic acid has been advo-
cated as a therapeutic agent to counteract hypersensitivity to various sulfona-
mides. The possibility that patients with a sulfonamide hypersensitivity could
also be hypersensitive to para-aminobenzoic acid explains why in some cases the
latter drug may make matters worse rather than counteract the clinical effects of
sulfonamide hypersensitivity. Indeed, several months ago one of us (L. M.) saw
a patient with dermatitis herpetiformis who developed dermatitis and agranu-
locytosis due to sulfapyridine. Administration of para-aminobenzoic acid
seemed to aggravate rather than improve his condition.
The one plus reaction to nupercaine cannot be explained on the basis of cross-
sensitization nor can the 2 plus reaction to saccharin unless the latter in its SO2
linkage to a benzene ring resembled the linkage in the sulfonamide drugs enough
to cause such a phenomenon.
The very strong cross-sensitization between sulfonamides, anesthetics and
paraphenylenediamine opens up alarming vistas as to possible sources of derma-
titis from this agent and a large group of dyes, a feature which we shall not take
up here as it has been discussed adequately in other papers by Mayer (13),
Dobkevitch and Baer (14), Baer, Leider and Mayer (15) and Baer (16).
Mention should also be made of the possible significance of the ingestion of
para-aminobenzoic acid as a vitamin factor in foods on the eruption in our pa-
tient. According to the patient's observations his eruption has not been influ-
enced by the ingestion of any particular foods. It appears extremely unlikely
that the minute quantities of para-aminobenzoic acid ingested in foods would be
capable of producing skin reactions in our patient.
SUMMARY AND CONCLUSIONS
A case of allergic eczematous contact-type hypersensitivity to glycerol para-
aminobenzoate, one of the modern filters in "sunburn preventives" is reported.
The sensitization to glycerol para-aminobenzoate was preceded by sensitization
to benzocaine and a sulfonamide (probably sulfaguanidine) which are also deriva-
tives of para-aminobenzoic acid. Sensitization to aniline (aminobenzene) was
present and probably was the basis of cross-sensitization to para-aminobenzoic
acid, many local anesthetics, sulfonamides, paraphenylenediamine and probably
many other agents.
The possible occurrence of dermatitis on the basis of cross-sensitization should
be considered before permitting the use of sunburn preventives containing para-
aminobenzoic acid or its esters in cases known to be hypersensitive to aniline,
paraphenylenediamine, local anesthetics and sulfonamides.
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